Feasibility and Safety Study of LAmbre Left Atrial Appendage Occluder
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Congxin Huang, MD
Renmin Hospital of Wuhan University,China
Principal Investigator - Lan Hieu Nguyen, MD
Hanoi Heart Hospital, Vietnam
Principal Investigator - Muhammad Munawar, MD
Binawaluya Hospital, Indonesia
Principal Investigator - Yan Yao, MD
Chinese Academy of Medical Sciences, Fuwai Hospital
Principal Investigator - Yat-Yin YY Lam, MD
Prince of Wales Hospital, Shatin, Hong Kong
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Prince of Wales Hospital
Hong Kong, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2012
- Primary completion
- 31 Oct 2013
- Completion
- 30 Sept 2014
- Last update posted
- 7 Aug 2018
- Registered enrollment
- 20
- Registry id
- NCT01920412
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.